abstract |
The invention provides a compound of formula (I): T is C(O) or S(O)<SUB>2</SUB>; W is CH<SUB>2</SUB>, (CH<SUB>2</SUB>)<SUB>2</SUB>, CH(CH<SUB>3</SUB>), CH(CH<SUB>3</SUB>)O or cyclopropyl; X is O, CH<SUB>2</SUB>, C(O), S, S(O), S(O)<SUB>2 </SUB>or NR<SUP>3</SUP>; m is 0 or 1; R<SUP>1 </SUP>is optionally substituted aryl or optionally substituted heterocyclyl; R<SUP>2 </SUP>is alkyl (optionally substituted by OH), cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis. |